患者中心决策支持工具对剖宫产后试产率的影响:PROCEED随机临床试验
这项多中心随机平行组试验纳入1485名有一次剖宫产史且无试产禁忌的孕妇,随机分为使用平板电脑决策支持工具组(n=742)和常规护理组(n=743),主要结局为试产率。结果显示两组试产率无显著差异(43.3% vs 46.2%,调整绝对风险差-2.78% [95%CI -7.80%至2.25%]),阴道分娩率也无显著差异(均为31.8%),其他母婴结局和决策质量指标均无显著差异。
要点
- 决策支持工具未显著提高剖宫产后试产率(43.3% vs 46.2%)。
- 两组阴道分娩率均为31.8%,无统计学差异。
- 决策质量等次要结局亦无显著改善。
核心结论
- 对于有一次剖宫产史的孕妇,使用决策支持工具与常规护理相比未显著改变试产率。
研究设计与样本
- 多中心、随机、平行组临床试验,在波士顿、芝加哥和旧金山湾区开展。
- 共纳入1485名有一次剖宫产史且无试产禁忌的英语或西班牙语孕妇,2016年1月至2019年1月入组,2019年6月完成随访。
- 参与者随机分为使用平板电脑决策支持工具组(n=742)和常规护理组(n=743),干预在妊娠25周前进行。
主要发现
- 试产率:干预组43.3%,对照组46.2%,调整绝对风险差-2.78%(95%CI -7.80%至2.25%),调整相对风险0.94(95%CI 0.84-1.05)。
- 阴道分娩率:两组均为31.8%,调整绝对风险差-0.04%(95%CI -4.80%至4.71%),调整相对风险1.00(95%CI 0.86-1.16)。
- 其他6项母婴临床次要结局均无统计学显著差异。
- 5项决策质量指标无显著差异,例如平均决策冲突评分干预组17.2、对照组17.5,调整均数差-0.38(95%CI -1.81至1.05);评分>25被认为有临床意义。
临床怎么用
- 该决策支持工具在改善剖宫产后试产率方面未显示优于常规护理的效果。
- 临床决策仍需结合患者具体情况,该工具的应用价值需进一步研究。
局限性
- 研究结论可能受限于特定临床设置和干预时机,工具在其他环境或妊娠其他阶段实施的效果尚需研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Reducing cesarean delivery rates in the US is an important public health goal; despite evidence of the safety of vaginal birth after cesarean delivery, most women have scheduled repeat cesarean deliveries. A decision support tool could help increase trial-of-labor rates. OBJECTIVE: To analyze the effect of a patient-centered decision support tool on rates of trial of labor and vaginal birth after cesarean delivery and decision quality. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, parallel-group clinical trial conducted in Boston, Chicago, and the San Francisco Bay area. A total of 1485 English- or Spanish-speaking women with 1 prior cesarean delivery and no contraindication to trial of labor were enrolled between January 2016 and January 2019; follow-up was completed in June 2019. INTERVENTIONS: Participants were randomized to use a tablet-based decision support tool prior to 25 weeks' gestation (n=742) or to receive usual care (without the tool) (n=743). MAIN OUTCOMES AND MEASURES: The primary outcome was trial of labor; vaginal birth was the main secondary outcome. Other secondary outcomes focused on maternal and neonatal outcomes and decision quality. RESULTS: Among 1485 patients (mean age, 34.0 [SD, 4.5] years), 1470 (99.0%) completed the trial (n = 735 in both randomization groups) and were included in the analysis. Trial-of-labor rates did not differ significantly between intervention and control groups (43.3% vs 46.2%, respectively; adjusted absolute risk difference, -2.78% [95% CI, -7.80% to 2.25%]; adjusted relative risk, 0.94 [95% CI, 0.84-1.05]). There were no statistically significant differences in vaginal birth rates (31.8% in both groups; adjusted absolute risk difference, -0.04% [95% CI, -4.80% to 4.71%]; adjusted relative risk, 1.00 [95% CI, 0.86-1.16]) or in any of the other 6 clinical maternal and neonatal secondary outcomes. There also were no significant differences between the intervention and control groups in the 5 decision quality measures (eg, mean decisional conflict scores were 17.2 and 17.5, respectively; adjusted mean difference, -0.38 [95% CI, -1.81 to 1.05]; scores >25 are considered clinically important). CONCLUSIONS AND RELEVANCE: Among women with 1 previous cesarean delivery, use of a decision support tool compared with usual care did not significantly change the rate of trial of labor. Further research may be needed to assess the efficacy of this tool in other clinical settings or when implemented at other times in pregnancy.
引用
- Kuppermann M, Kaimal AJ, Blat C, et al. Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean Delivery: The PROCEED Randomized Clinical Trial. JAMA. 2020. PMID: 32484533. doi:10.1001/jama.2020.5952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。